
1. j law med. 2018 oct;26(1):208-213.

regulating rna research crispr gene drives combat biosecurity threats.

faunce t(1), ray a(2), gardiner c(3), preiss t(4), burgio g(5).

author information: 
(1)professor, anu law school medical school.
(2)research associate, anu law school.
(3)lecturer, anu law school.
(4)professor john curtin school medical research.
(5)professor, john curtin school medical research, anu law school.

recent technological breakthroughs ribonucleic acid (rna) research the
creation synthetic gene drives using crispr/cas9 increased attention on
the ethical legal regulation field. rna perceived not
merely passive carrier dna information especially propensity
to mutate computation engine cell biology, developmental biology and
evolution. synthetic gene drives hailed potential strategy to
reduce climate-change-mediated biosecurity threats spreading malaria 
have attracted significant investment, gates foundation pledging us$75
million defense advanced research projects agency awarding us$65 million.
calls global moratorium rna-mediated genetic engineering may overstate
the potential risks developing technology, form background the
contest "process"- "product" -based approaches regulation, the
former purportedly favoured public regulatory agencies latter 
favoured broad scientific community corporate investors. stake may 
be democratic legitimacy equitable access technology could
be important reduce incidence biosecurity threats globally 
australia.


pmid: 30302983  [indexed medline]

